Waters Corporation vs Pfizer

Side-by-side comparison of AI visibility scores, market position, and capabilities

Pfizer leads in AI visibility (93 vs 76)
Waters Corporation logo

Waters Corporation

LeaderHealthcare Tech

Analytical Instruments

Waters Corporation (WAT) reported ~$2.97B revenue in FY2024. Premier maker of liquid chromatography instruments and mass spectrometers used in pharmaceutical quality control and research. HQ: Milford, MA.

AI VisibilityBeta
Overall Score
B76
Category Rank
#70 of 596
AI Consensus
85%
Trend
stable
Per Platform
ChatGPT
79
Perplexity
73
Gemini
74

About

Waters Corporation is the global leader in analytical instruments and detection technologies for the life science, pharmaceutical, and materials science industries, best known for its high-performance liquid chromatography (HPLC) systems, ultra-high performance liquid chromatography (UPLC) platforms, and mass spectrometry instruments used in drug discovery, quality control, and regulatory compliance. Founded in 1958 by Jim Waters, the company pioneered the commercialization of HPLC technology that is now the standard method for separating and analyzing chemical mixtures in pharmaceutical manufacturing.

Full profile
Pfizer logo

Pfizer

LeaderHealthcare Tech

Enterprise

Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 596
AI Consensus
80%
Trend
up
Per Platform
ChatGPT
94
Perplexity
89
Gemini
94

About

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.

Full profile

AI Visibility Head-to-Head

76
Overall Score
93
#70
Category Rank
#1
85
AI Consensus
80
stable
Trend
up
79
ChatGPT
94
73
Perplexity
89
74
Gemini
94
73
Claude
92
75
Grok
98

Key Details

Category
Analytical Instruments
Enterprise
Tier
Leader
Leader
Entity Type
company
company

Capabilities & Ecosystem

Capabilities

Only Waters Corporation
Analytical Instruments

Integrations

Only Waters Corporation
Only Pfizer
Waters Corporation is classified as company. Pfizer is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.